Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1
- PMID: 12626640
- DOI: 10.1124/jpet.102.048611
Phenyl N-tert-butylnitrone down-regulates interleukin-1 beta-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2-terminal kinase, p38-mitogen-activated protein kinase and activating protein-1
Abstract
Cytokine-mediated induction and overexpression of matrix metalloproteinases (MMPs) is recognized as an important factor in the pathogenesis of arthritis. Interleukin (IL)-1 beta is a proinflammatory cytokine that is known to superinduce the expression and production of MMP-13 in many cell types. Phenyl N-tert-butylnitrone (PBN), a spin trap agent, inhibited the IL-1 beta-induced expression of MMP-13 in human osteoarthritis (OA) chondrocytes. Down-regulation of MMP-13 expression correlated with the inhibition of mitogen-activated protein kinase (MAPK) subgroups c-Jun NH2-terminal kinase (JNK) and p38-MAPK activation, accumulation of phospho-c-jun, and the DNA binding activity of activating protein-1 (AP-1). Results of in vitro kinase assays showed that exogenously added PBN completely blocked the c-Jun phosphorylating activity of JNK. Interestingly, using in vitro kinase assay, we also found that chondrocyte p38-MAPK phosphorylate c-Jun and that PBN was not very effective in inhibiting c-Jun phosphorylating activity of p38-MAPK. In addition, PBN did not block the ATF-2 phosphorylating activity of p38-MAPK and Elk-1 phosphorylating activity of extracellular regulated kinase p44/p42 in vitro, indicating that PBN may act selectively to inhibit the phosphorylation of c-Jun in OA chondrocytes. Together, our results for the first time demonstrate that PBN suppresses the IL-1 beta-stimulated expression of MMP-13 in OA chondrocytes and that this was achieved by inhibiting the activation of JNK and AP-1. These results suggest that use of PBN or compounds derived from it may be of potential benefit in inhibiting signaling events associated with cartilage degradation in arthritis.
Similar articles
-
Epigallocatechin-3-gallate selectively inhibits interleukin-1beta-induced activation of mitogen activated protein kinase subgroup c-Jun N-terminal kinase in human osteoarthritis chondrocytes.J Orthop Res. 2003 Jan;21(1):102-9. doi: 10.1016/S0736-0266(02)00089-X. J Orthop Res. 2003. PMID: 12507586
-
Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3.Arthritis Rheum. 2000 Apr;43(4):801-11. doi: 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4. Arthritis Rheum. 2000. PMID: 10765924
-
Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.Arthritis Rheum. 2001 Jan;44(1):73-84. doi: 10.1002/1529-0131(200101)44:1<73::AID-ANR11>3.0.CO;2-E. Arthritis Rheum. 2001. PMID: 11212179
-
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.Science. 2002 Dec 6;298(5600):1911-2. doi: 10.1126/science.1072682. Science. 2002. PMID: 12471242 Review.
-
Mixed-lineage kinase control of JNK and p38 MAPK pathways.Nat Rev Mol Cell Biol. 2002 Sep;3(9):663-72. doi: 10.1038/nrm906. Nat Rev Mol Cell Biol. 2002. PMID: 12209126 Review.
Cited by
-
Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.Nanomedicine. 2015 Nov;11(8):2033-40. doi: 10.1016/j.nano.2015.07.003. Epub 2015 Aug 6. Nanomedicine. 2015. PMID: 26255114 Free PMC article. Review.
-
Molecular Targets of Natural Products for Chondroprotection in Destructive Joint Diseases.Int J Mol Sci. 2020 Jul 13;21(14):4931. doi: 10.3390/ijms21144931. Int J Mol Sci. 2020. PMID: 32668590 Free PMC article. Review.
-
Role of interleukin-1 inhibitors in osteoarthritis: an evidence-based review.Drugs Aging. 2012 May 1;29(5):343-58. doi: 10.2165/11599350-000000000-00000. Drugs Aging. 2012. PMID: 22550965 Review.
-
Early relief of osteoarthritis symptoms with a natural mineral supplement and a herbomineral combination: a randomized controlled trial [ISRCTN38432711].J Inflamm (Lond). 2005 Oct 21;2:11. doi: 10.1186/1476-9255-2-11. J Inflamm (Lond). 2005. PMID: 16242032 Free PMC article.
-
Glucosamine affects intracellular signalling through inhibition of mitogen-activated protein kinase phosphorylation in human chondrocytes.Arthritis Res Ther. 2007;9(5):R104. doi: 10.1186/ar2307. Arthritis Res Ther. 2007. PMID: 17925024 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous